<VariationArchive RecordType="classified" VariationID="4405" VariationName="NM_020919.4(ALS2):c.138del (p.Ala47fs)" VariationType="Deletion" Accession="VCV000004405" Version="3" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2022-04-25" DateCreated="2013-10-01" MostRecentSubmission="2020-02-24">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="19444" VariationID="4405">
      <GeneList>
        <Gene Symbol="ALS2" FullName="alsin Rho guanine nucleotide exchange factor ALS2" GeneID="57679" HGNC_ID="HGNC:443" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>2q33.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="201700267" stop="201780933" display_start="201700267" display_stop="201780933" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="202564985" stop="202645894" display_start="202564985" display_stop="202645894" Strand="-" />
          </Location>
          <OMIM>606352</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_020919.4(ALS2):c.138del (p.Ala47fs)</Name>
      <CanonicalSPDI>NC_000002.12:201767265:T:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>2q33.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="201767266" stop="201767266" display_start="201767266" display_stop="201767266" variantLength="1" positionVCF="201767265" referenceAlleleVCF="CT" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="202631989" stop="202631989" display_start="202631989" display_stop="202631989" variantLength="1" positionVCF="202631988" referenceAlleleVCF="CT" alternateAlleleVCF="C" />
      </Location>
      <OtherNameList>
        <Name>c.138delA(A261del)</Name>
      </OtherNameList>
      <ProteinChange>A47fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.11" sequenceAccession="NC_000002" sequenceVersion="11" change="g.202631989del" Assembly="GRCh37">
            <Expression>NC_000002.11:g.202631989del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.12" sequenceAccession="NC_000002" sequenceVersion="12" change="g.201767266del" Assembly="GRCh38">
            <Expression>NC_000002.12:g.201767266del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001135745.2" sequenceAccession="NM_001135745" sequenceVersion="2" change="c.138del">
            <Expression>NM_001135745.2:c.138del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001129217.1" sequenceAccession="NP_001129217" sequenceVersion="1" change="p.Ala47fs">
            <Expression>NP_001129217.1:p.Ala47fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_020919.4" sequenceAccession="NM_020919" sequenceVersion="4" change="c.138del" MANESelect="true">
            <Expression>NM_020919.4:c.138del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_065970.2" sequenceAccession="NP_065970" sequenceVersion="2" change="p.Ala47fs">
            <Expression>NP_065970.2:p.Ala47fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_654" sequenceAccession="LRG_654">
            <Expression>LRG_654:g.18907del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_654t1" sequenceAccession="LRG_654t1">
            <Expression>LRG_654t1:c.138del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_654p1" sequenceAccession="LRG_654p1" change="p.Ala47fs">
            <Expression>LRG_654p1:p.Ala47fs</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008775.1" sequenceAccession="NG_008775" sequenceVersion="1" change="g.18907del">
            <Expression>NG_008775.1:g.18907del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="386134173" DB="dbSNP" />
        <XRef ID="CA340238" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="606352.0001" DB="OMIM" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_020919.4(ALS2):c.138del (p.Ala47fs) AND Amyotrophic lateral sclerosis type 2, juvenile" Accession="RCV000004655" Version="7">
        <ClassifiedConditionList TraitSetID="1212">
          <ClassifiedCondition DB="MedGen" ID="C1859807">Amyotrophic lateral sclerosis type 2, juvenile</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2011-02-10" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2011-02-10" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2013-10-01" MostRecentSubmission="2020-02-24">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <CitationText>Hadano, S. Personal Communication. 2002. Isehara, Japan</CitationText>
        </Citation>
        <Citation Type="general">
          <CitationText>Hentati, A., Bejaoui, K., Pericak-Vance, M. A., Hentati, F., Yen-Hung, W., Figlewicz, D. A., Ben Hamida, C., Ben Hamida, M., Brown, R. H., Jr., Siddique, T. The gene locus for one form of juvenile amyotrophic lateral sclerosis maps to chromosome 2. (Abstract) Am. J. Hum. Genet. 51 (suppl.): A33-only, 1992.</CitationText>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">11586297</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">11586298</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">16321985</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">2328408</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">7920663</ID>
        </Citation>
        <Citation Type="review" Abbrev="GeneReviews">
          <ID Source="PubMed">20301421</ID>
          <ID Source="BookShelf">NBK1243</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="1212" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="297" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Amyotrophic lateral sclerosis type 2</ElementValue>
                <XRef ID="Amyotrophic+Lateral+Sclerosis+Type+2/404" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Amyotrophic lateral sclerosis type 2, juvenile</ElementValue>
                <XRef ID="MONDO:0008780" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">ALS, JUVENILE</ElementValue>
                <XRef Type="MIM" ID="205100" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">ALS2</ElementValue>
                <XRef Type="MIM" ID="205100" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">ALSJ</ElementValue>
                <XRef Type="MIM" ID="205100" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">ALS2-related disorder involves retrograde degeneration of the upper motor neurons of the pyramidal tracts and comprises a clinical continuum of the following three phenotypes: Infantile ascending hereditary spastic paraplegia (IAHSP), characterized by onset of spasticity with increased reflexes and sustained clonus of the lower limbs within the first two years of life, progressive weakness and spasticity of the upper limbs by age seven to eight years, and wheelchair dependence in the second decade with progression toward severe spastic tetraparesis and a pseudobulbar syndrome caused by progressive cranial nerve involvement. Juvenile primary lateral sclerosis (JPLS), characterized by upper motor neuron findings of pseudobulbar palsy and spastic quadriplegia without dementia or cerebellar, extrapyramidal, or sensory signs. Juvenile amyotrophic lateral sclerosis (JALS or ALS2), characterized by onset between ages three and 20 years. All affected individuals show a spastic pseudobulbar syndrome (spasticity of speech and swallowing) together with spastic paraplegia. Some individuals are bedridden by age 12 to 50 years.</Attribute>
                <XRef ID="NBK1243" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="9470" />
                <XRef ID="9470" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301421</ID>
                <ID Source="BookShelf">NBK1243</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301623</ID>
                <ID Source="BookShelf">NBK1450</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="Orphanet, 2007">
                <URL>https://www.orpha.net/data/patho/Pro/en/Emergency_AmyotrophicLateralSclerosis.pdf</URL>
                <CitationText>Orphanet, Amyotrophic lateral sclerosis, 2007</CitationText>
              </Citation>
              <XRef ID="300605" DB="Orphanet" />
              <XRef ID="C1859807" DB="MedGen" />
              <XRef ID="MONDO:0008780" DB="MONDO" />
              <XRef Type="MIM" ID="205100" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="24829" SubmissionDate="2020-02-21" DateLastUpdated="2020-02-24" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="606352.0001_AMYOTROPHIC LATERAL SCLEROSIS 2, JUVENILE" title="ALS2, 1-BP DEL, 138A_AMYOTROPHIC LATERAL SCLEROSIS 2, JUVENILE" />
        <ClinVarAccession Accession="SCV000024829" DateUpdated="2020-02-24" DateCreated="2013-04-04" Type="SCV" Version="3" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2001-10-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In affected members of a Tunisian family with juvenile amyotrophic lateral sclerosis-2 (ALS2; 205100) reported by Ben Hamida et al. (1990) and Hentati et al. (1992, 1994), Yang et al. (2001) and Hadano et al. (2001) identified a homozygous 1-bp deletion (138delA) in exon 3 of the ALS2 gene, resulting in a frameshift and a premature stop codon 4 codons after the deletion site. The 1-bp deletion occurred in codon 46 for alanine and the premature stop was at codon 50. The deletion affected both the long and short forms of the protein. The mutation was not identified in 533 control individuals (Hadano et al., 2001).</Attribute>
              <Citation>
                <ID Source="PubMed">2328408</ID>
              </Citation>
              <Citation>
                <CitationText>Hentati, A., Bejaoui, K., Pericak-Vance, M. A., Hentati, F., Yen-Hung, W., Figlewicz, D. A., Ben Hamida, C., Ben Hamida, M., Brown, R. H., Jr., Siddique, T. The gene locus for one form of juvenile amyotrophic lateral sclerosis maps to chromosome 2. (Abstract) Am. J. Hum. Genet. 51 (suppl.): A33-only, 1992.</CitationText>
              </Citation>
              <Citation>
                <ID Source="PubMed">7920663</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">11586297</ID>
              </Citation>
              <Citation>
                <CitationText>Hadano, S. Personal Communication. 2002. Isehara, Japan</CitationText>
              </Citation>
              <XRef DB="OMIM" ID="205100" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Hadano (2002) pointed out that this mutation, which Hadano et al. (2001) identified as 261delA, should be referred to as 138delA.</Attribute>
              <Citation>
                <ID Source="PubMed">16321985</ID>
              </Citation>
              <Citation>
                <CitationText>Hadano, S. Personal Communication. 2002. Isehara, Japan</CitationText>
              </Citation>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ALS2" />
          </GeneList>
          <Name>ALS2, 1-BP DEL, 138A</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DEL, 138A</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="606352.0001" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">AMYOTROPHIC LATERAL SCLEROSIS 2, JUVENILE</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="99636" SubmissionDate="2013-04-30" DateLastUpdated="2013-10-01" DateCreated="2013-05-03">
        <ClinVarSubmissionID localKey="c.138delA(A261del)_NBK1243" title="c.138delA(A261del) and ALS2-Related Disorders" />
        <ClinVarAccession Accession="SCV000058584" DateUpdated="2013-10-01" DateCreated="2013-05-03" Type="SCV" Version="2" SubmitterName="GeneReviews" OrgID="500062" OrganizationCategory="resource" OrgAbbreviation="GeneReviews" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2011-02-10">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>pathologic</GermlineClassification>
          <Comment>Converted during submission to Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>not provided</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <Purpose>Assert pathogenicity</Purpose>
              <MethodType>curation</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="nucleotide change">c.138delA(A261del)</Name>
          </OtherNameList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">ALS2-Related Disorders</ElementValue>
            </Name>
            <XRef DB="GeneReviews" ID="NBK1243" />
            <XRef DB="OMIM" ID="205100" Type="MIM" />
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="24829" TraitType="Disease" MappingType="Name" MappingValue="AMYOTROPHIC LATERAL SCLEROSIS 2, JUVENILE" MappingRef="Preferred">
        <MedGen CUI="C1859807" Name="Amyotrophic lateral sclerosis type 2, juvenile" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="99636" TraitType="Disease" MappingType="Name" MappingValue="ALS2-Related Disorders" MappingRef="Preferred">
        <MedGen CUI="CN169291" Name="ALS2-Related Disorders" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

